← Leaderboards
Parkash Singh Gill
University Of Southern California
$3,455,725
Attributed
$3,455,725
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $345.3K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,455,725 · 6
By mechanism
R01$2,926,381 · 1
M01$347,081 · 2
P30$182,263 · 2
P20$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Caryn Lerman$95,133,528
- Heinz Josef Lenz$20,123,312
- David Ian Quinn$4,779,068
- Anthony Boutros El-Khoueiry$6,814,457
- Michael R Lieber$20,714,841
Others in their field
Top investigators on “Kaposi'S Sarcoma”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$112,355,819
- Ronald T Mitsuyasu · University Of California Los Angeles$103,289,310
- David Heimbrook · Leidos Biomedical Research, Inc.$100,149,252
- Jae U Jung · Cleveland Clinic Lerner Com-Cwru$47,112,192
- Michael Shannon McGrath · University Of California San Francisco$33,859,029
- Blossom A Damania · University Of North Carolina Chapel Hill$31,849,711
Research focus
Kaposi'S SarcomaClinical ResearchHuman SubjectNeoplasm /Cancer ChemotherapyVascular Endothelial Growth FactorsHuman Therapy EvaluationAids Related Neoplasm /CancerAutocrineCell Growth RegulationTumorPaclitaxelReceptorBlood VesselsImmunologic Assay /TestDrug MetabolismBioimagingBasic ScienceAntibodiesCell TherapyCell LineCompanionsCytokineClinical SciencesClinic
Grant awards (23)
Translational and Clinical Sciences Research Program (Project-007)$52,780
P30 · FY2019 · CA · contact PI
Translational and Clinical Sciences Research Program (Project-007)$52,779
P30 · FY2018 · CA · contact PI
Translational and Clinical Sciences Research Program (Project-007)$2,029
P30 · FY2018 · CA · contact PI
Translational and Clinical Sciences Research Program (Project-007)$48,042
P30 · FY2017 · CA · contact PI
Translational and Clinical Sciences Research Program (Project-007)$26,633
P30 · FY2016 · CA · contact PI
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma$328,425
R01 · FY2009 · CA · contact PI
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma$328,425
R01 · FY2008 · CA · contact PI
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma$328,425
R01 · FY2007 · CA · contact PI
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma$337,976
R01 · FY2006 · CA · contact PI
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma$345,313
R01 · FY2005 · CA
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA$325,803
R01 · FY2003 · CA
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA$317,691
R01 · FY2002 · CA
PACLITAXEL IN ADV REFRACTORY KAPOSIS SARCOMA (AIDS KS)$0
M01 · FY2002 · RR
INHIBITORS OF MATURATION OF NEWLY FORMING BLOOD VESSELS$0
P20 · FY2002 · CA
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA$310,293
R01 · FY2001 · CA
PACLITAXEL IN ADV REFRACTORY KAPOSIS SARCOMA (AIDS KS)$155,764
M01 · FY2001 · RR
INHIBITORS OF MATURATION OF NEWLY FORMING BLOOD VESSELS$0
P20 · FY2001 · CA
PACLITAXEL IN ADV REFRACTORY KAPOSIS SARCOMA (AIDS KS)$0
M01 · FY2001 · RR
VEGF AND RELATED PROTEINS IN AIDS RELATED KAPOSI SARCOMA$304,030
R01 · FY2000 · CA
PACLITAXEL IN ADV REFRACTORY KAPOSIS SARCOMA (AIDS KS)$155,764
M01 · FY2000 · RR
PACLITAXEL IN ADV REFRACTORY KAPOSIS SARCOMA (AIDS KS)$35,553
M01 · FY2000 · RR
AMC011: COL-3 IN PTS WITH HIV RELATED KAPOSI'S SARCOMA$0
M01 · FY2000 · RR
AMC011: COL-3 IN PTS WITH HIV RELATED KAPOSI'S SARCOMA$0
M01 · FY2000 · RR